Researchers at Seoul National University Report New Data on Health Insurance (True rise in anaphylaxis incidence Epidemiologic study based on a…

Researchers at Seoul National University Report New Data on Health Insurance (True rise in anaphylaxis incidence Epidemiologic study based on a national health insurance database)

By a News Reporter-Staff News Editor at Managed Care Weekly Digest -- Current study results on Health Insurance have been published. According to news reporting from Seoul, South Korea, by NewsRx journalists, research stated, "The incidence trend of anaphylaxis in Asia is not well investigated. The aim of this study is to estimate the entire population-based incidence of anaphylaxis in Korea using a nationwide administrative database."

The news correspondents obtained a quote from the research from Seoul National University, "Data over a 7-year period (2008-2014) was obtained from the Korean National Health Insurance (NHI) claims database which covers 97.9% of the entire Korean population. Using diagnosis codes from the International Classification of Diseases-10 for anaphylaxis (T78.0, T78.2, T80.5, and T88.6), we identified the annual number of patients who had visited any hospital with a primary diagnosis of anaphylaxis. Incidence rates were calculated using the population distribution data of all NHI beneficiaries. The incidence of anaphylaxis in Korea was 32.19 episodes per 100,000 person-years in 2014, which nearly doubled from 2008 (16.02 episodes per 100,000 person-years). The incidence of anaphylaxis increased continuously throughout these years regardless of gender and age groups (P for trend < 0.001). Female was significantly less predisposed than male (adjusted odds ratio [OR], 0.69; 95% confident interval [CI], 0.66-0.72; P< 0.001). The incidence was the lowest in 0 to 19 age group and the highest in 40 to 69 age group (adjusted OR, 2.41; 95% CI, 2.29-2.54; P< 0.001)."

According to the news reporters, the research concluded: "We report the increasing time trend of anaphylaxis incidence rates using nationwide claims database for the first time in Asia."

For more information on this research see: True rise in anaphylaxis incidence Epidemiologic study based on a national health insurance database. Medicine, 2017;96(5):51-55. Medicine can be contacted at: Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA. (Elsevier - www.elsevier.com; Medicine - www.journals.elsevier.com/medicine/)

Our news journalists report that additional information may be obtained by contacting H.R. Kang, Seoul National University, Drug Safety Monitoring Center, Seoul, South Korea. Additional authors for this research include J.Y. Kim, B.K. Kim, H.W. Park, S.H. Cho, K.U. Min and H.R. Kang (see also Health Insurance).

Keywords for this news article include: Seoul, South Korea, Asia, Insurance Companies, Health Insurance, Seoul National University.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC